第一个三个月的孕激素治疗和妊娠糖尿病之间的关系
Asaf Romano1, Lior Friedrich1, Gil Zeevi1
1Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
European journal of obstetrics, gynecology, and reproductive biology
|October 30, 2025
概括
辅助生殖技术 (ART) 怀孕显示出更高的妊娠糖尿病 (GDM) 率. 然而,像母亲年龄和BMI这样的因素,而不是ART方法,似乎是GDM风险的主要驱动因素.
科学领域:
- 生殖医学 生殖医学
- 内分泌学 在内分泌学.
- 产科 产科 产科 产科 产科
背景情况:
- 辅助生殖技术 (ART) 怀孕与妊娠期糖尿病 (GDM) 风险增加有关.
- 导致GDM的特定ART因素仍然不清楚,而孕激素的使用是研究的关键领域.
研究的目的:
- 为了比较通过ART怀孕的单独怀孕和自发怀孕之间的GDM发病率.
- 调查孕激素给药途径对ART组内GDM比率的影响.
主要方法:
- 对19,849个单独怀孕的回顾性队列研究.
- 在ART和自发受孕组之间的GDM率的比较,不包括孕期糖尿病和以后的孕激素暴露.
- 多变量回归分析调整了诸如产妇年龄,BMI和平价等混因素.
主要成果:
- 与自发怀孕 (7.2%) 相比,ART怀孕的原始GDM率 (12.7%) 较高.
- 在调整了母亲年龄,BMI和nulliparity后,这种关联不再显著.
- 在ART组中,孕激素的服用途径没有显著影响GDM的发病率.
结论:
- 虽然ART怀孕显示出更高的GDM率,但先前存在的孕产妇因素 (年龄,BMI,平价) 比ART特定的治疗方法 (如第一季度孕激素) 更有影响力.
- 这些发现有助于GDM风险分层和为接受ART的妇女提供患者咨询.
相关概念视频
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Hypoglycemia and Glucagon
796
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
796
Oral Hypoglycemic Agents: Biguanides and Glitazones
571
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
571
Insulin: Dosing Regimen and Adverse Effects
670
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
670
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


